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Edited by Richard MaraisAbstract Cellular response to a hypertonic environment is
important for ﬂuid clearance in the lung. Hypertonicity modu-
lates prostaglandin synthesis by inﬂuencing cyclooxygenase-2
(COX-2) expression in tissues such as liver and kidney via a
mitogen-activated protein kinase (MAPK)-dependent pathway.
However, little is known about COX-2 expression in response
to hypertonicity in the lung. COX-2 mRNA accumulation in-
duced by hypertonic NaCl was detected after 1 h of treatment,
and COX-2 mRNA continued to accumulate until 18 h, the lon-
gest time point examined, in human alveolar epithelial A549
cells. This induction was a transcriptional event that occurred
in the absence of the protein synthesis inhibitor cycloheximide
and was the result of enhanced promoter activity, as examined
with the use of full-length COX-2 promoter-driven reporter plas-
mids. The induction of COX-2 expression by hypertonic NaCl
did not require the activation of NF-jB. The p38 MAPK inhib-
itor, SB203580, or MEK1/2 inhibitor, U0126, inhibited hyper-
tonic induction of COX-2 expression. We examined whether
the hypertonic induction of COX-2 was under the inﬂuence of
glucocorticoid; we found that COX-2 promoter activity and
mRNA and protein levels were depressed by dexamethasone
and antagonized by the glucocorticoid receptor (GR) antagonist
RU486. Our data demonstrate that the induction of COX-2
expression by hypertonic NaCl occurs independently of NF-jB
and is inhibited by the GR in A549 cells.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
Keywords: COX-2; Hypertonic sodium chloride; NF-jB;
Glucocorticoid receptor; Alveolar epithelial cells1. Introduction
Salt and water transport play an important role in alveolar
ﬂuid clearance (AFC), and active sodium ion transport drives
osmotic water transport in the lung. The alveoli must remain
open and free from ﬂuid for eﬃcient gas exchange to occur
[1]. Intact AFC, therefore, is critical in clearing ﬂuid from the
lungs at birth and keeping the alveolar space relatively ﬂuid-free
for adequate gas exchange under physiological conditions [2–4].*Corresponding author. Fax: +82 2 3408 3334.
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doi:10.1016/j.febslet.2005.08.077One enzyme that may be involved in this process is cycloox-
ygenase (COX), a key regulatory enzyme in the biosynthesis of
prostaglandins (PGs) from arachidonic acid [5]. COX-2 has a
diverse assortment of biological functions in mammalian tis-
sues, such as regulation of vascular tone, expression and secre-
tion of rennin, and salt and water homeostasis in the kidneys
[6]. Recent studies on the eﬀects of salt on COX-2 expression
in the kidney have identiﬁed some mechanisms for the regula-
tion of COX-2 expression. It was reported that a low-salt med-
ium regulates COX-2 expression by p38- and NF-jB-
dependent signaling pathways in cultured cortical cells from
the thick ascending limb of the loop of Henle [6,7]. Hypertonic
NaCl activated COX-2 in renal medullary interstitial cells
through the transactivation of the epidermal growth factor
receptor [8]. Pathways involving the transcription factor
NF-jB and mitogen-activated protein kinase (MAPK) play a
central role in the high-salt-mediated regulation of COX-2
expression in mammalian kidney cells [9,10]. All three mem-
bers of the MAPK family (ERK, JNK-2, and p38) as well as
Src kinases are required for tonicity-stimulated COX-2 expres-
sion in inner medullary collecting duct cells [10].
Cellular dysfunction induced by hypertonic NaCl in alveolar
epithelial cells could play an important role in the lung ﬂuid
balance under both normal and pathological conditions. Saline
infusion has been reported to have a signiﬁcant inﬂuence on
inﬂammation-related gene expression in the lung [11]. Previous
studies have shown that the inhibition of prostaglandin synthe-
sis inhibits the ﬂow of liquid from the fetal lungs [12–14]. How-
ever, the eﬀects of hypertonic stress on COX-2 expression in
alveolar epithelial cells and the mechanism involved are not
known. In the present study, we examined the hypertonic
NaCl induction of COX-2 expression in the human alveolar
epithelial cell line A549.2. Materials and methods
2.1. Materials
Cycloheximide, pyrrolidine dithiocarbamate (PDTC), SB203580,
U0126, urea, NaCl, mannitol, 3-(5 0-hydroxymethyl-2 0-furyl)-1-benzyl-
indazole (YC-1), aldosterone, spironolactone, dexamethasone, RU486,
12-O-tetradecanoylphorbol-13-acetate (TPA) and Dulbeccos modiﬁed
Eagles medium (DMEM)/Hams F12 were purchased from Sigma (St.
Louis, MO, USA). Fetal calf serum (FCS), Trizol Reagent, and peni-
cillin/streptomycin were purchased from GIBCO Invitrogen (Grand
Island, NY, USA).blished by Elsevier B.V. All rights reserved.
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A549 cells, a human pulmonary epithelial cell line, were grown in
DMEM/Hams F12 nutrient mixture containing 10% FCS and penicil-
lin/streptomycin in a humidiﬁed 37 C incubator. COX-2-Luc, a ﬁreﬂy
luciferase reporter construct containing the mouse COX-2 gene pro-
moter fragment (3.4 kb), 327/+59, a ﬁreﬂy luciferase reporter dele-
tion construct of the human COX-2 promoter, KBM, an NF-jB
binding region site-speciﬁc mutant of 327/+59, ha ENaC-Luc, a ﬁre-
ﬂy luciferase reporter construct containing the human a ENaC pro-
moter fragment (1.4 kb), and 3 · (NF-jB)tk-Luc, a ﬁreﬂy luciferase
reporter construct containing three repeated NF-jB-responsive ele-
ments, were kindly provided Dr. Huifang Cheng (Vanderbilt Univer-
sity School of Medicine, Tennessee, USA) [6], Dr. Hiroyasu Inoue
(Nara Womens University, Nara, Japan) [15], Dr. Christie P. Thomas
(University of Iowa College of Medicine and the Veterans Aﬀairs Med-
ical Center, Iowa, USA) [16], and Dr. Sam Okret (Karolinska Univer-
sity Hospital Huddinge, Huddinge, Sweden) [17], respectively. A549
cells were transiently transfected with COX-2-Luc, 327/+59, KBM,
ha ENaC-Luc, or 3 · (NF-jB)tk-Luc by electroporation. Electropora-
tion was performed with a Gene Pulser II (Bio-Rad, Hercules, CA,
USA). Cells were trypsinized, washed in cold PBS, and resuspended
in PBS. A 400 ll portion of the suspension was mixed with 20 lg of
plasmid DNA.
After 5 min at room temperature, cells were pulsed at 1000 lF and
250 V. After 10 min incubation at 37 C, the suspension was diluted
in medium and cultured for 24 h. Cells were replaced with fresh med-
ium and treated with high salt (100 mM NaCl; 200 mosmol/kgH2O) to
the normal medium resulting in ﬁnal osmolarity of 500 mosmol/kgH2O
or pretreated with speciﬁc inhibitors for 30 min before treatment of
high salt for 18 h. After treatment, the cells were harvested and lysed
with reporter lysis buﬀer (Promega Luciferase Assay system). The cell
extract was mixed with the luciferase assay reagent and analyzed by
the luminometer (Lumat LB 9507, EG&G Berthold, Bad Widbad,
Germany).2.3. Reverse transcription-PCR
Total RNA was extracted using Trizol Reagent according to the man-
ufacturers instruction. RNA pellets were dissolved in diethylpyrocarbon-
ate-treated water. The yield of RNA was quantiﬁed by spectroscopy at
260 nm. Samples were aliquoted and stored at 80 C until further pro-
cessing. To synthesize ﬁrst strand cDNA, 3 lg total RNA was incubated
at 70 C for 5 min with 0.5 lg of random hexamer and deionized water
(up to 11 ll). The reverse transcription (RT) reaction was performed using
40 U of M-MLV reverse transcriptase (Promega, Madison, WI, USA) in
5 · reaction buﬀer (250 mmol/l Tris–HCl; pH 8.3, 375 mM KCl, 15 mM
MgCl2, 50 mM DTT), RNase inhibitor at 1 U/ll, and 1 mM dNTP mix-
tures at 37 C for 60 min. The reaction was terminated by heating at 70 C
for 10 min, followed by cooling at 4 C. The resulting cDNAwas added to
the PCRmixture containing 10 · PCR buﬀer (100 mMTris–HCl, pH 8.3,
500 mMKCl, 15 mMMgCl2), 25 U of rTaq polymerase (TakaRa, Shiga,
Japan), 4 ll of 2.5 mMdNTPmixtures, and 10 pmol of primers each. The
ﬁnal volume was 50 ll. Samples were ampliﬁed at 94 C for 5 min, 23 cy-
cles of 94 C for 45 s, 55 C for 45 s, and 72 C for 45 s usingMastercycler
gradient (Eppendorf, Hamburg, Germany). b-actin was ampliﬁed for 20
cycles, followed by 72 C for 5 min. The primers used were: COX-2 sense
primer, 50-TTCAAATGAGATTGTGGGAAAATTGCT-30; COX-2
antisense primer, 50-AGATCATCTCTGCCTGAGTATCTTT-30[18];
b-actin sense primer, 50-CCTGACCCTGAAGTACCCCA-30, b-actin
antisense primer, 50-CGTCATGCAGCTCATAGCTC-30; IL-8 sense pri-
mer, 50-AAGGAACCATCTCACTG-30, IL-8 antisense primer, 50-GAT-
TCTTGGATACCACAGAG-30. The expected size of amplicons for
COX-2, -actin, and IL-8 are 305, 550, 500, and 369 bp, respectively.2.4. Western blot analysis
Protein extracted from A549 cells was isolated in lysis buﬀer
(150 mM NaCl, 50 mM Tris–HCl, 5 mM EDTA, 1% Nonidet P-40,
0.5% deoxycholate, 1% SDS) with protease inhibitor cocktail (Sigma)
on ice for 1 h and then centrifuged for 20 min at 13000 · g. Superna-
tant was collected and protein concentrations were measured using
the Bradford method (Bio-Rad). Proteins were dissolved in sample
buﬀer and boiled for 5 min prior to loading onto an acrylamide gel.
After SDS–PAGE, proteins were transferred to a polyvinylidene
diﬂuoride membrane, blocked with 5% non-fat dry milk in Tris-buf-
fered saline containing 0.1% Tween-20 (TBST) for 60 min at roomtemperature. The membranes were incubated for 2 h at room temper-
ature with 1:1000 dilution of COX-2 polyclonal antibody (Cayman,
Ann Arbor, MI, USA). Equal lane loading was assessed using b-actin
monoclonal antibody (Sigma). After washing with TBST, blots were
incubated with 1:5000 dilution of the horseradish peroxidase conju-
gated-secondary antibody (Zymed, San Francisco, CA, USA), and
washed again three times with TBST. The transferred proteins were
visualized with an enhanced chemiluminescence detection kit (Amer-
sham Pharmacia Biotech, Buckinghamshire, UK).
2.5. Statistical analysis
Data were expressed as means ± S.E.M., and statistical analysis for
single comparison was performed using the Students t test. The crite-
rion for statistical signiﬁcance was P < 0.05.3. Results
3.1. Hypertonic NaCl induces COX-2 mRNA and protein
expression in A549 cells
We determined the eﬀects of hypertonic NaCl on COX-2
expression in A549 cells by using RT-PCR and Western blot
analyses. A549 cells were treated with 100 mM NaCl,
200 mM urea, or 200 mM mannitol to the normal medium
resulting in ﬁnal osmolarity of 500 mosmol/kgH2O. As shown
in Fig. 1A, membrane-permeable urea did not aﬀect the COX-
2 protein levels, but the membrane-impermeable agents, NaCl
and mannitol, increased COX-2 protein levels in the A549
cells. This observation indicates that the induction of COX-2
regulation in A549 cells in the presence of a high salt concen-
tration occurs in response to cell volume changes by tonicity
rather than by the osmolarity of the surrounding ﬂuid. The
A549 cells were treated with hypertonic NaCl for 0, 0.5, 1, 2,
4, 6, or 18 h. COX-2 mRNA was not detected after 0 or
0.5 h of the high salt treatment, but COX-2 mRNA was de-
tected after 1 h and continued to accumulate until 18 h. To
examine whether the induction of COX-2 mRNA was the re-
sult of increased transcription from the COX-2 promoter, we
performed a reporter assay using a luciferase construct con-
taining the full-length mouse COX-2 promoter. As shown in
Fig. 1C, hypertonic NaCl signiﬁcantly increased the luciferase
activity of the full-length COX-2 promoter in the A549 cells.
We examined whether the hypertonic NaCl induction of
COX-2 gene expression requires protein synthesis by pre-treat-
ing A549 cells for 2 h with or without cycloheximide (10 lg/
ml), a protein synthesis inhibitor, and then incubating the cells
in the presence or absence of 100 mM NaCl for 18 h. As a po-
sitive control, we performed RT-PCR for interleukin-8 (IL-8)
[19]. The increased expression of COX-2 mRNA induced by
the high-salt medium was not aﬀected by cycloheximide pre-
treatment (Fig. 1D), although cycloheximide alone signiﬁ-
cantly increased IL-8 mRNA in the A549 cells. This result
suggests that protein synthesis is not involved and indicates
that the response is elicited by pre-existing transcription fac-
tor(s), possibly by NF-jB.
3.2. Hypertonic NaCl regulation of COX-2 is not mediated by
NF-jB in A549 cells
The transcription factor NF-jB is important in the hyper-
tonic NaCl regulation of COX-2 in kidney cells [9]. The bind-
ing of activated NF-jB to the COX-2 promoter region is
critical for COX-2 transcriptional activation in a number of
cell types [20–22]. NF-jB is a positive regulator of COX-2
expression in macrophages and colon carcinoma cell lines
Fig. 1. Hypertonic NaCl increases COX-2 mRNA and protein expression in A549 cells. (A) A549 cells were treated with the indicated solutes (Urea,
200 mM urea; HS, 100 mM NaCl; mannitol, 200 mM mannitol) to the normal medium for 18 h. After incubation, the cell lysates were subjected to
10% SDS–PAGE and transferred to polyvinylidene diﬂuoride membrane. Immunoblots were probed with a COX-2 antibody and reprobed with actin
antibody. Bands were visualized by an ECL method, as described in Section 2. The immunoblot is representative of three independent experiments
eliciting similar pattern. (B) A549 cells were treated with high salt (100 mM NaCl) for indicated time periods. Total RNA from A549 cells were
analyzed for COX-2 mRNA expression by RT-PCR using speciﬁc primers as described in Section 2. Data presented are representative of two
independent experiments showing similar trend. (C) A549 cells were transfected with COX-2-Luc and treated as indicated. After treatment, luciferase
expression was determined as described in Section 2. Values represent the means ± S.E.M. (N = 3). *Represents P < 0.05. (D) A549 cells were
pretreated with cycloheximide (10 lg/ml) for 2 h before incubation with 100 mMNaCl for 18 h. Total RNA from A549 cells were analyzed for COX-
2 and IL-8 mRNA expression by RT-PCR assays. Data presented are representative of two independent experiments showing similar trend. con,
untreated cells; HS, 100 mM NaCl; CHX, cycloheximide; IL-8, interleukin-8.
5432 W.C. Lim et al. / FEBS Letters 579 (2005) 5430–5436[23,24]. Studies have shown that IL-1b or lipopolysaccharide
induces COX-2 expression via NF-jB activation in many cells
including A549 cells [25–28]. To determine if NF-jB is
involved in the hypertonic NaCl-induced COX-2 expression
in A549 cells, we evaluated the eﬀects of NF-jB inhibitors.
We pretreated A549 cells with 5 lM MG132, a proteasome
inhibitor that has been shown to prevent IjB degradation
and thereby NF-jB activation [29], or 100 lM PDTC, fol-
lowed by incubation in hypertonic NaCl for 18 h. As shown
in Fig. 2A–C, neither MG132 nor PDTC inhibited COX-2
expression or promoter activation in cells exposed to hypertonic
NaCl. No reduction in hypertonic NaCl induced COX-2 expres-
sion with MG132 or PDTC suggests that COX-2 activation
occurs in the absence of NF-jB activation. Interestingly, we
have consistently observed increased COX-2 protein expres-
sion with MG132 as compared with that of high salt
(Fig. 2A, lanes 2 and 3). Similar results were observed in
M-1 mouse cortical collecting duct cell (our unpublished
results). We do not exactly understand how MG132 synergis-
tically activates COX-2 in our model system. MG132 may acti-
vate upstream targets of hypertonic COX-2 activation by
triggering other signaling transduction pathways independent
of protein degradation [30].
To further determine the importance of NF-jB activation, we
performed reporter assay using luciferase construct driven by
the 5 0-ﬂanking region of the COX-2 promoter (327/+59) con-
taining NF-jB binding site. The COX-2 promoter (327/+59)
showed less than 2-fold activation in response to 100 mMNaCl
(Fig. 2D). The 0.3 kb COX-2 promoter fragment with mutationat the NF-jB site (223/214) also had a marginal eﬀect on
luciferase expression (Fig. 2D). As a positive control for
KBM, we used TPA [15]. These data suggest that NF-jB bind-
ing element is not critical in COX-2 upregulation by high salt in
A549 cells. Furthermore, the hypertonic NaCl did not aﬀect
NF-jB-dependent luciferase expression in A549 cells. As a
positive control for NF-jB-dependent gene transcription, we
used YC-1, an activator of soluble guanylate cyclase, which ini-
tiates IKKa/b and NF-jB activation [31] (Fig. 2E). These
observations indicate that NF-jB is not activated by hypertonic
NaCl and imply that, although both salt and cytokines induce
COX-2 expression, diﬀerent signaling mechanisms exist for
the hypertonic NaCl and cytokine induction of COX-2.
3.3. The hypertonic NaCl regulation of COX-2 in A549 cells is
mediated by MEK1/2 and p38 MAPK
Study has shown that MAPK family members play a role in
COX-2 gene expression induced by a hypertonic medium,
which is crucial for cell survival under hyperosmotic shock
[10]. The MAPK p38 is an essential component of the hyper-
tonic signaling response pathway in mammals and is a major
regulator in COX-2 upregulation [32–35]. To study the
involvement of the MAPK pathway in the hypertonic NaCl
induction of COX-2 expression in A549 cells, we evaluated
the eﬀects of p38 and MEK1/2 inhibitors on COX-2 expres-
sion. We pretreated A549 cells with SB203580 (a p38 MAPK
inhibitor) or U0126 (a MEK1/2 inhibitor) for 30 min and then
co-treated the cells with hypertonic NaCl for 18 h. The high-
salt induction COX-2 mRNA and protein expression was
Fig. 2. NF-jB is not involved in hypertonic NaCl induction of COX-2 in A549 cells. (A) A549 cells were pretreated with PDTC (100 lM) or MG132
(5 lM) for 30 min before incubation with 100 mM NaCl for 18 h. Immunoblots were probed with a COX-2 antibody and reprobed with actin
antibody, as described in Section 2. (B) A549 cells were pretreated with PDTC (100 lM) or MG132 (5 lM) for 30 min before incubation with
100 mM NaCl for 18 h. Total RNA from A549 cells were analyzed for COX-2 mRNA expression by RT-PCR assays, as described in Section 2. (C)
A549 cells were transfected with COX-2-Luc and treated as indicated. After treatment, luciferase expression was determined as described in Section 2.
Values represent the means ± S.E.M. (N = 3). (D) A549 cells were transfected with 327/+59 or KBM and treated as indicated. After treatment,
luciferase expression was determined as described in Section 2. Values represent the means ± S.E.M. (N = 3). (E) A549 cells were transfected with the
3 · (NF-jB)tk-Luc and treated as indicated. After treatment, luciferase expression was determined. Values represent the means ± S.E.M. (N = 3).
*Represents P < 0.05. con, untreated cells; HS, 100 mM NaCl. All experiments were repeated at least twice.
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Furthermore, hypertonic NaCl-mediated full-length COX-2
promoter driven luciferase activity was partially inhibited by
SB203580 and U0126 (Fig. 3C). It appears that p38 and
MEK1/2 pathways aﬀect not only at the level of transcription
but also that of post-transcription in high-salt induction COX-
2 expression in A549 cells. These results suggest that the acti-
vation of the p38 and MEK1/2 pathways is critical for the
induction of COX-2 in A549 cells by a high-salt medium.Fig. 3. MEK1/2 and p38 MAPK are involved in hypertonic NaCl induction
(10 lM) or SB203580 (10 lM) for 30 min before incubation with 100 mM N
reprobed with actin antibody, as described in Section 2. Data presented are re
A549 cells were pretreated with U1026 (10 lM) or SB203580 (10 lM) for 30
A549 cells were analyzed for COX-2 mRNA expression by RT-PCR assays,
Luc and treated as indicated. After treatment, luciferase expression was dete
(N = 3). con, untreated cells; HS, 100 mM NaCl; SB, SB203580. The immuno
pattern.3.4. Dexamethasone inhibits hypertonic NaCl induction of
COX-2 expression in A549 cells
Glucocorticoids regulate sodium uptake and ﬂuid transport
in both adult and fetal lungs, and studies have shown that a
single dexamethasone injection increases AFC [36–40]. Dexa-
methasone suppresses COX-2 expression in the myelomonocy-
tic leukemia cell line U937 [41]. The glucocorticoid receptor
(GR) is involved in the tonic suppression of renal cortical
COX-2 expression in animals [42]. To examine the possibleof COX-2 in A549 cells. (A) A549 cells were pretreated with U1026
aCl for 18 h. Immunoblots were probed with a COX-2 antibody and
presentative of two independent experiments showing similar trend. (B)
min before incubation with 100 mM NaCl for 18 h. Total RNA from
as described in Section 2. (C) A549 cells were transfected with COX-2-
rmined as described in Section 2. Values represent the means ± S.E.M.
blot is representative of three independent experiments eliciting similar
Fig. 4. Dexamethasone inhibits hypertonic NaCl induction of COX-2 in A549 cells. (A) A549 cells were pretreated with dexamethasone (0.01 or
0.1 lM) and/or RU486 (1 lM) for 1 h before incubation with 100 mM NaCl for 18 h. Total RNA from A549 cells were analyzed for COX-2 mRNA
expression by RT-PCR assays, as described in Section 2. Data are representative of two independent experiments. (B) A549 cells were pretreated with
dexamethasone (0.01 or 0.1 lM) and/or RU486 (1 lM) for 1 h before incubation with 100 mM NaCl for 18 h. Immunoblots were probed with a
COX-2 antibody and reprobed with actin antibody, as described in Section 2. Blots are representative of four independent experiments showing
similar pattern. (C) A549 cells were transfected with COX-2-Luc and treated as indicated. After treatment, luciferase expression was determined as
described in Section 2. Experiments were repeated four times. (D) A549 cells were pretreated with aldosterone (0.1 lM) for 1 h before incubation with
100 mM NaCl for 18 h. Immunoblots were probed with a COX-2 antibody and reprobed with actin antibody. Blots are representative of two
independent experiments showing similar pattern. Values represent the means ± S.E.M. (N = 3). *Represents P < 0.05. con, untreated cells; HS,
100 mM NaCl; Dex, dexamethasone; Aldo, aldosterone. Experiments were repeated twice.
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A549 cells, we pre-incubated cells with dexamethasone and/or
the GR antagonist RU486 for 1 h and co-treated with NaCl.
Neither dexamethasone nor RU486 in the absence of high salt
had an eﬀect on the COX-2 protein level or promoter activity.
However, dexamethasone did block the hypertonic NaCl-
induced COX-2 mRNA (Fig. 4A) and protein (Fig. 4B) expres-
sion, and COX-2 promoter activity (Fig. 4C). The suppressive
eﬀect of dexamethasone was antagonized by the GR antago-
nist RU486, suggesting that the response is mediated by the
GR and glucocorticoid-speciﬁc. To further determine the spec-
iﬁcity of the inhibitory eﬀect of dexamethasone on salt-induced
COX-2 regulation, we examined whether aldosterone exhibits
similar suppressive eﬀects. Cells were pre-incubated with aldo-
sterone and/or the mineralocorticoid receptor antagonist spi-
ronolactone for 1 h and were co-treated with NaCl for 18 h.
As shown in Fig. 4D, the application of aldosterone did not
have an eﬀect on the hypertonic NaCl induction of COX-2
protein expression in A549 cells. As a positive control, we per-
formed an aENaC promoter-driven reporter gene assay; aldo-
sterone signiﬁcantly increased aENaC-dependent reporter
gene transcription, and spironolactone blocked this induction
(data not shown). These results indicate that dexamethasone
inhibits hypertonic NaCl-induced COX-2 regulation through
the GR in A549 cells.4. Discussion
We studied the induction of COX-2 by hypertonic NaCl in
lung epithelial A549 cells and observed that NaCl increasesCOX-2 expression at the level of transcription. Our study sug-
gests that p38 andMEK1/2, and not NF-jB, are involved in the
signal transduction leading to the expression of COX-2 induced
by hypertonic NaCl. The NaCl induction of COX-2 in the lung
cells could be a non-speciﬁc inﬂammatory-related response, but
urea, a hyperosmotic agent that can promote cell lysis and can
be irritating to cells, did not induce COX-2 in our study. COX-2
induction was observed in response to an increase in tonicity.
The hypertonic NaCl induction of COX-2 has been studied
most intensively in kidney tissue [6,7,9,10,43]. The expression
of COX-2 in the kidney is tissue-speciﬁc; COX-2 is downregu-
lated in the cortex and upregulated in the medulla [44]. Despite
intensive in vivo and in vitro studies, the mechanism of the dif-
ferential regulation in the kidney has not been elucidated. Our
results show that hypertonic NaCl activates COX-2 expression
in lung epithelial cells, as occurs in rat kidney medulla and inner
medullary collecting duct cells [9,10,43].
The ﬁrst candidate we investigated as a transcription factor
responsible for COX-2 gene activation in lung epithelial cells
was NF-jB. Studies have previously shown that hypertonic
stress activates an NF-jB-COX-2-linked survival mechanism
in renal medullary interstitial cells [43]. Other studies have
shown that the inhibition of glycogen synthase kinase-3b pro-
tects renal cells from hypertonic stress via the induction of the
NF-jB-COX-2-dependent pathway [9]. However, in contrast
to the situation in the kidney medulla, the hypertonic activa-
tion of COX-2 in lung epithelial cells was not dependent on
NF-jB. In addition, it appears that part of the signal transduc-
tion pathway leading to COX-2 activation is shared but is not
identical with other stimuli, such as LPS and cytokines. The
NaCl induction of COX-2 was inhibited by a glucocorticoid,
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LPS and cytokines [45–47], while dexamethasone suppressed
LPS- and IL-1b-induced COX-2 regulation in a NF-jB-depen-
dent manner. Recent studies have shown that the inhibition of
granulocyte-macrophage colony-stimulating factor by dexa-
methasone is independent of NF-jB [48,49], and the inhibition
of NF-jB cannot account for all the repressive eﬀects of dexa-
methasone on inﬂammatory genes such as COX-2 [50]. The
transcription factor involved in the hypertonic NaCl activation
of COX-2 remains to be identiﬁed, but it is most likely a pre-
existing protein(s) rather than a newly synthesized protein, as
shown by the cycloheximide experiments. It is possible that
the factor is speciﬁc to the lung; however, we have observed
the hypertonic NaCl activation of COX-2 in other cells, such
as vascular smooth muscle (data not shown), which indicates
that the response is not restricted to lung and kidney tissues.
A few transcription factors activated by hypertonicity are
known. One well-known example is tonicity-responsive enhan-
cer (TonE) binding protein (TonEBP). TonEBP is a member of
the Rel family of transcriptional activators that include NF-jB
and nuclear factor of activated T cells [51]. Studies have previ-
ously shown that the hypertonic induction of COX-2 mRNA is
not reduced by the expression of DN-TonEBP [52]. However,
additional studies are needed to conﬁrm that the hypertonic
induction of COX-2 is independent of TonEBP. The identiﬁca-
tion of the transcription factor responsible for the hypertonic
NaCl induction of COX-2 would greatly enhance our under-
standing of the hypertonicity-triggered signal transduction
pathway that leads to COX-2 activation.
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